3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Hepatoblastoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
GATA2 Deficiency
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Anemia, Refractory
1
Interventions
Specimen Handling
5
Nivolumab
5
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
Biopsy
3
dehydroftorafur
2
Sigmoidoscopy
2
Radiotherapy, Intensity-Modulated
2
Proctoscopy
2
Paclitaxel
2
Mitozytrex
2
Mitomycin
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Colonoscopy
2
Carboplatin
2
Capecitabine
2
trastuzumab deruxtecan
1
entinostat
1
bintrafusp alfa protein, human
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Surveys and Questionnaires
1
Sentinel Lymph Node Biopsy
1
Radiotherapy
1
Radionuclide Imaging
1
Radiation
1
Phantoms, Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Vorinostat
×
90 days
×
Clear all
No trials found.